Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Capital Expenditures: 2011-2024

Historic Capital Expenditures for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to $2.4 million.

  • Abeona Therapeutics' Capital Expenditures rose 523.76% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 295.74%. This contributed to the annual value of $2.4 million for FY2024, which is 638.97% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Capital Expenditures of $2.4 million as of FY2024, which was up 638.97% from $331,000 recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Capital Expenditures ranged from a high of $4.2 million in FY2021 and a low of $130,000 during FY2022.
  • In the last 3 years, Abeona Therapeutics' Capital Expenditures had a median value of $331,000 in 2023 and averaged $969,000.
  • As far as peak fluctuations go, Abeona Therapeutics' Capital Expenditures crashed by 96.87% in 2022, and later surged by 638.97% in 2024.
  • Abeona Therapeutics' Capital Expenditures (Yearly) stood at $1.3 million in 2020, then surged by 210.70% to $4.2 million in 2021, then tumbled by 96.87% to $130,000 in 2022, then surged by 154.62% to $331,000 in 2023, then soared by 638.97% to $2.4 million in 2024.